Searched for
SUN PHARMA PROMOTER
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Why did the stock market fall today? Sensex tumbles 1,300 pts, Nifty below 23,850. 6 key factorsIndian stock markets experienced a significant downturn on Monday. The Sensex and Nifty saw sharp declines as oil prices surged. Fading hop...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Ram Shriram's Sherpalo Ventures to lead $60 million funding round in Skyroot; valuation hits $1.1 billionGIC, of Singapore, BlackRock, Greenko Group founders take part in round along with Sun Pharma founder Dilip Shanghvi family office as the 9...
- Sun Pharma gets relief in trademark case from High CourtThe Bombay High Court has ruled in favour of Sun Pharmaceutical Industries. The court has restrained United Biotech from using a similar tr...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Reliance Industries to set up India’s largest data centre cluster in Andhra PradeshRIL is set to invest ₹1.6 lakh cr (over $17 bn) to develop a 1.5 GW AI-focused data centre cluster along with a captive solar and battery s...
- Sun Pharma wins trademark case against Navi Mumbai companyThe Bombay High Court has ruled against a Navi Mumbai drugmaker. The court prohibited the use of brand names 'Absun' and 'Absun Pharma'. Th...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- High Court relief to Sun Pharma, Ahd Co barred from using 'Esiraft'Sun Pharmaceutical Industries has received a significant legal victory. The Bombay High Court has stopped Meghmani Lifesciences from using ...
- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
- Sun Pharma promoter Vibha Shanghvi buys two luxury apartments in Mumbai’s Worli for Rs 130 croreVibha Shanghvi, wife of Sun Pharmaceuticals Founder Dilip Shanghvi, purchased two luxury apartments in Mumbai's Worli for Rs 130 crore. The...
- Shanghvi Finance raises stake in Sun PharmaShares of Sun Pharma ended up 6.6 per cent at Rs 393.35 on Tuesday.
- Sun to overhaul business practices to allay concernsSun Pharma's domestic formulations biz would be transitioned from Aditya Medisales to a wholly owned arm.
- There is no diversion of funds at all: Sudhir Valia, director, Sun PharmaSudhir Valia, brother-in-law of Sun Pharma promoter Dilip Shanghvi, in a telephonic chat with Divya Rajagopal, discusses the issues of Adit...
- Sun promoters pledged firm's shares for SurakshaShanghvi's brother-in-law and realty co owner Valia denies drugmaker stood guarantee for fundraising.
- Sun Pharma's promoters to be Telenor's new Indian JV partnerAfter months of searching, Telenor has finally found a new partner for its telecom operations in India - Sun Pharma's promoters.
- Sun Pharma promoters plan power sector foray; stock upThe promoters of India's fourth-largest pharmaceuticals company Sun Pharma are planning a Rs 5,000-crore foray into the power sector.
- Sun Pharma promoters plan power sector forayThe promoters of India's fourth-largest pharmaceuticals company Sun Pharma are planning a Rs 5,000-crore foray into the power sector, conti...
Load More
